Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential Teriparatide and Raloxifene in Postmenopausal Osteoporosis
NCT00035256Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Oct 2001
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of raloxifene in osteoporosis, sponsored by Eli Lilly and Company. Started Oct 2001; status: completed.
02
Drugs
raloxifene
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00035256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00035256.